HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Takayuki Maruyama Selected Research

ONO4819

9/2006Effects of a prostaglandin EP4 agonist, ONO-4819, and risedronate on trabecular microstructure and bone strength in mature ovariectomized rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Takayuki Maruyama Research Topics

Disease

21Neoplasms (Cancer)
05/2017 - 01/2002
14Inflammation (Inflammations)
01/2016 - 04/2003
13Periodontitis
01/2021 - 12/2008
12Carcinogenesis
11/2009 - 01/2002
8Stroke (Strokes)
10/2012 - 03/2007
7Brain Ischemia (Cerebral Ischemia)
10/2012 - 03/2007
7Colonic Neoplasms (Colon Cancer)
11/2009 - 01/2002
5Neoplasm Metastasis (Metastasis)
01/2016 - 02/2007
5Brain Injuries (Brain Injury)
01/2016 - 01/2009
5Infarction (Infarctions)
10/2012 - 03/2007
4Bone Resorption
01/2022 - 04/2002
4Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
10/2012 - 03/2007
3Chronic Periodontitis
01/2021 - 03/2019
3Melanoma (Melanoma, Malignant)
12/2015 - 02/2007
3Ischemic Stroke
09/2010 - 03/2009
3Ischemia
03/2009 - 10/2008
3Adenocarcinoma
08/2008 - 05/2005
2Periodontal Diseases (Periodontal Disease)
06/2022 - 09/2012
2Pancreatic Neoplasms (Pancreatic Cancer)
07/2016 - 08/2008
2Osteolysis
01/2016 - 02/2007
2Prostatic Neoplasms (Prostate Cancer)
01/2016 - 02/2010
2Neurologic Manifestations (Neurological Manifestations)
01/2016 - 10/2012
2Experimental Melanoma
12/2015 - 01/2008
2Carcinoma (Carcinomatosis)
09/2015 - 05/2005
2Neuroinflammatory Diseases
05/2015 - 07/2010
2Fibrosis (Cirrhosis)
01/2015 - 12/2003
2Bone Fractures (Bone Fracture)
06/2012 - 04/2012
2Necrosis
01/2011 - 03/2006
2Colorectal Neoplasms (Colorectal Cancer)
03/2006 - 01/2003
2Intestinal Polyps
05/2005 - 07/2003
1Obesity
06/2022
1Immune System Diseases (Immune Disorders)
01/2022
1Alveolar Bone Loss
03/2020
1Stomatitis
01/2019
1Pharyngeal Neoplasms
01/2019
1Fever (Fevers)
12/2018
1Esophageal Neoplasms (Esophageal Cancer)
12/2018
1Non-alcoholic Fatty Liver Disease
01/2017
1Type 2 Diabetes Mellitus (MODY)
01/2017
1Cholangiocarcinoma
07/2016

Drug/Important Bio-Agent (IBA)

27ProstaglandinsIBA
01/2022 - 01/2002
13Dinoprostone (PGE2)FDA Link
01/2016 - 03/2006
13Prostaglandins EIBA
08/2011 - 01/2002
9Prostaglandin E Receptors (Prostaglandin E Receptor)IBA
02/2010 - 01/2002
7MicroRNAs (MicroRNA)IBA
06/2022 - 01/2016
7Biomarkers (Surrogate Marker)IBA
01/2021 - 09/2012
6Proteins (Proteins, Gene)FDA Link
07/2016 - 02/2005
6Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
08/2012 - 01/2003
58-Hydroxy-2'-DeoxyguanosineIBA
03/2020 - 01/2009
5Cyclooxygenase 2 (Cyclooxygenase-2)IBA
09/2012 - 01/2002
4Messenger RNA (mRNA)IBA
06/2022 - 01/2002
4Lysine (L-Lysine)FDA Link
10/2011 - 12/2008
4ONO 8711IBA
03/2007 - 07/2003
4AzoxymethaneIBA
03/2006 - 01/2002
3Prostaglandin D2IBA
09/2015 - 01/2008
3ONO 8713IBA
08/2012 - 01/2006
3Peptide Hydrolases (Proteases)FDA Link
10/2011 - 12/2008
3LipopolysaccharidesIBA
10/2011 - 12/2008
3N-Methylaspartate (NMDA)IBA
09/2010 - 12/2008
37- chloro- 3- imino- 5- methyl- 2- azabicyclo(4.1.0)heptaneIBA
08/2008 - 03/2006
3Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
08/2008 - 03/2006
2CoffeeFDA Link
03/2020 - 10/2014
2C-Reactive ProteinIBA
05/2017 - 01/2017
2Prostaglandins FIBA
10/2012 - 01/2009
2prostaglandin F2alpha receptorIBA
10/2012 - 01/2009
24- (4- cyano- 2- (2- (4- fluoronaphthalen- 1- yl)propionylamino)phenyl)butyric acidIBA
08/2012 - 02/2010
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2012 - 01/2003
2Celecoxib (Celebrex)FDA Link
08/2012 - 01/2006
2Streptozocin (Streptozotocin)FDA Link
07/2012 - 10/2008
2EnzymesIBA
07/2012 - 12/2008
2Lipid PeroxidesIBA
10/2011 - 12/2008
23-nitrotyrosineIBA
01/2011 - 05/2009
2LipidsIBA
05/2009 - 01/2008
2Ascorbic Acid (Vitamin C)FDA LinkGeneric
05/2009 - 01/2009
2Glucose (Dextrose)FDA LinkGeneric
03/2009 - 12/2008
2Oxygen (Dioxygen)IBA
03/2009 - 12/2008
2Glutathione Disulfide (GSSG)FDA LinkGeneric
01/2009 - 12/2008
2HeptanesIBA
08/2008 - 03/2006
2Nitric Oxide (Nitrogen Monoxide)FDA Link
03/2006 - 10/2003
2Transforming Growth Factor beta (TGF-beta)IBA
12/2003 - 07/2002
1Poly I-CIBA
01/2022
1Pattern Recognition ReceptorsIBA
01/2022
1Toll-Like Receptors (Toll-Like Receptor)IBA
01/2022
1Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
12/2018
1Benzethonium (Magic, Formula)IBA
12/2018
1CarbohydratesIBA
05/2017
1AntigensIBA
05/2017
1Hemoglobins (Hemoglobin)IBA
01/2017
1Vitamin EFDA LinkGeneric
07/2016
1AntioxidantsIBA
07/2016

Therapy/Procedure

5Therapeutics
01/2021 - 02/2007
5Ligation
01/2020 - 12/2008
3Chemoprevention
11/2009 - 07/2003
2Tooth Extraction (Tooth Extractions)
01/2021 - 01/2021
2Oral Hygiene (Dental Hygiene)
12/2018 - 01/2017
2Topical Administration
06/2012 - 04/2012
2Microspheres (Microsphere)
06/2012 - 04/2012
1Precision Medicine
01/2021
1Chemoradiotherapy
01/2019
1Glycemic Control
01/2017